BGC > Product Search > Dolutegravir

Description :
Dolutegravir is a two-metal-binding HIV-1 integrase inhibitor with IC50 of 2.7 nM, with modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. It blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI).

• Molecular Weight :419.38
• Boiling Point :669.0±55.0 °C at 760 mmHg
• Purity :≥98%

Molecular Formula :
C20H19F2N3O5
Canonical SMILES :
CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
InChI :
InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
InChIKey :
RHWKPHLQXYSBKR-BMIGLBTASA-N
Solubility :
In Vitro: DMSO : 10 mg/mL(23.84 mM;Need ultrasonic and warming) In Vivo: 1.Add each solvent one by one:5% DMSO > > 95% (20%SBE-β-CDin saline) Solubility: ≥ 2.62 mg/mL (6.25 mM); Clear solution 2.Add each solvent one by one:10% DMSO > > 40%PEG300 > > 5%Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution 3.Add each solvent one by one:10% DMSO > > 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution 4.Add each solvent one by one:10% DMSO > > 90%corn oil Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution
Appearance :
White to off-white (Solid)
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
GSK-1349572; GSK 1349572; GSK1349572; Tivicay

More details are to be found here

Description :
Dolutegravir is a two-metal-binding HIV-1 integrase inhibitor with IC50 of 2.7 nM, with modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. It blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI).

• Molecular Weight :419.38
• Boiling Point :669.0±55.0 °C at 760 mmHg
• Purity :≥98%

Molecular Formula :
C20H19F2N3O5
Canonical SMILES :
CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
InChI :
InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
InChIKey :
RHWKPHLQXYSBKR-BMIGLBTASA-N
Solubility :
In Vitro: DMSO : 10 mg/mL(23.84 mM;Need ultrasonic and warming) In Vivo: 1.Add each solvent one by one:5% DMSO > > 95% (20%SBE-β-CDin saline) Solubility: ≥ 2.62 mg/mL (6.25 mM); Clear solution 2.Add each solvent one by one:10% DMSO > > 40%PEG300 > > 5%Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution 3.Add each solvent one by one:10% DMSO > > 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution 4.Add each solvent one by one:10% DMSO > > 90%corn oil Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution
Appearance :
White to off-white (Solid)
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
GSK-1349572; GSK 1349572; GSK1349572; Tivicay

More details are to be found here

Description :
Dolutegravir is a two-metal-binding HIV-1 integrase inhibitor with IC50 of 2.7 nM, with modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. It blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI).

• Molecular Weight :419.38
• Boiling Point :669.0±55.0 °C at 760 mmHg
• Purity :≥98%

Molecular Formula :
C20H19F2N3O5
Canonical SMILES :
CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
InChI :
InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
InChIKey :
RHWKPHLQXYSBKR-BMIGLBTASA-N
Solubility :
In Vitro: DMSO : 10 mg/mL(23.84 mM;Need ultrasonic and warming) In Vivo: 1.Add each solvent one by one:5% DMSO > > 95% (20%SBE-β-CDin saline) Solubility: ≥ 2.62 mg/mL (6.25 mM); Clear solution 2.Add each solvent one by one:10% DMSO > > 40%PEG300 > > 5%Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution 3.Add each solvent one by one:10% DMSO > > 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution 4.Add each solvent one by one:10% DMSO > > 90%corn oil Solubility: ≥ 2.5 mg/mL (5.96 mM); Clear solution
Appearance :
White to off-white (Solid)
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
GSK-1349572; GSK 1349572; GSK1349572; Tivicay

More details are to be found here